Gender Differences in Suicidal and Self-Harming Responses to Esketamine: A Real-World Retrospective Study
Current Neuropharmacology October 20, 2025 Vassilis Martiadis, Fabiola Raffone, Danilo Atripaldi et al. 21 citations
Esketamine rapidly improved suicidality and depression in TRD, with preliminary evidence suggesting gender-specific responses, and highlighting the importance of tailored interventions to maximize outcomes. Further research is needed to confirm these differences, explore the long-term effects, and understand the underlying mechanisms.